Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Works by Howey, Daniel C
Results: 17
1
2
Effects of a Potent and Selective PPAR-a Agonist in Patients With Atherogenic Dyslipidemia or Hypercholesterolemia.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 12, p. 1362, doi. 10.1001/jama.297.12.1362
- By:
- Publication type:
- Article
3
Response to Comment on: Bergenstal et al. A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. Diabetes Care 2012;35:2140-2147.
- Published in:
- 2013
- By:
- Publication type:
- Letter
4
Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type2 Diabetes. Diabetes Care 2012;35: 2140-2147.
- Published in:
- Diabetes Care, 2013, v. 36, n. 7, p. e107, doi. 10.2337/dc13-0295
- By:
- Publication type:
- Article
5
Better glycemic control and weight loss with the novel long-acting basal insulin LY2605541 compared with insulin glargine in type 1 diabetes: a randomized, crossover study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
6
Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes.
- Published in:
- Diabetes Care, 2013, v. 36, n. 3, p. 522, doi. 10.2337/dc12-0067
- By:
- Publication type:
- Article
7
Single-dose pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 in healthy subjects.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 7, p. 792, doi. 10.1002/jcph.276
- By:
- Publication type:
- Article
8
Single-Dose Pharmacokinetics and Glucodynamics of the Novel.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 2, p. 1, doi. 10.1002/jcph.276
- By:
- Publication type:
- Article
9
A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes.
- Published in:
- 2012
- By:
- Publication type:
- journal article
10
A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin--Treated PatientsWith Type 2 Diabetes.
- Published in:
- Diabetes Care, 2012, v. 35, n. 11, p. 2140, doi. 10.2337/dc12-0060
- By:
- Publication type:
- Article
11
Comparative pharmacokinetics and glucodynamics of two human insulin mixtures. 70/30 and 50/50 insulin mixtures.
- Published in:
- 1994
- By:
- Publication type:
- journal article
12
Establishment of time-action profiles for regular and NPH insulin using pharmacodynamic modeling.
- Published in:
- 1994
- By:
- Publication type:
- journal article
13
Biosynthetic Human Proinsulin.
- Published in:
- Diabetes Care, 1992, v. 15, n. 5, p. 666, doi. 10.2337/diacare.15.5.666
- By:
- Publication type:
- Article
14
[Lys(B28), Pro(B29)]-human insulin: Effect of injection time on postprandial glycemia.
- Published in:
- Clinical Pharmacology & Therapeutics, 1995, v. 58, n. 4, p. 459, doi. 10.1016/0009-9236(95)90060-8
- By:
- Publication type:
- Article
15
The therapeutic efficacy of human insulin (recombinant DNA) in patients with insulin-dependent diabetes mellitus: a comparative study with purified porcine insulin.
- Published in:
- 1982
- By:
- Publication type:
- journal article
16
Short-term effects of a high-fiber, high-carbohydrate diet in very obese diabetic individuals.
- Published in:
- 1982
- By:
- Publication type:
- journal article
17
[Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin.
- Published in:
- 1994
- By:
- Publication type:
- journal article